ACM
NVS icon

Accent Capital Management’s Novartis NVS Stock Holding History

Accent Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.6K Sell
438
-16
-4% -$2.4K 0.03% 103
2026
Q1 		$69.3K Buy
+454
New +$69.6K 0.03% 84
2025
Q4 		– Sell
-40
Closed -$5.13K – 370
2025
Q3 		$5.13K Hold
40
– – ﹤0.01% 320
2025
Q2 		$4.84K Hold
40
– – ﹤0.01% 334
2025
Q1 		$4.62K Buy
+40
New +$4.26K ﹤0.01% 260
2024
Q3 		– Sell
-350
Closed -$37.3K – 217
2024
Q2 		$37.3K Buy
+350
New +$35.1K 0.02% 104

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Accent Capital Management's NVS Position: Q2 2026 in Review

Accent Capital Management reduced its Novartis (NVS) stake by 3.5% in Q2 2026, selling an estimated $2.4K and leaving 438 shares worth $68.6K. The position accounts for 0.03% of the portfolio, ranked #103.

Accent Capital Management first reported a position in NVS in Q2 2024 and has held it in 6 quarters since. The position peaked at $69.3K in Q1 2026. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Accent Capital Management held 438 shares of Novartis worth $68.6K as of Q2 2026.
  • Accent Capital Management sold 16 Novartis shares in Q2 2026, an estimated $2.4K.
  • Novartis made up 0.03% of Accent Capital Management's portfolio in Q2 2026, its #103 holding.
  • Accent Capital Management first reported a position in Novartis in Q2 2024 and has held it in 6 quarters since.
  • Accent Capital Management's Novartis position peaked at $69.3K in Q1 2026.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.